Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1333154-77-0
101187-39-7
139115-90-5
1800414-71-4
857891-82-8
208987-04-6
1392275-56-7 | L-Alanine, N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1) | AA001AGB | MFCD30534429
139494-68-1 | Sodium tris(1,1,1,3,3,3-hexafluoroisopropoxy)borohydride | AA001B1S | MFCD16295193
1398504-35-2 | N,N-Dimethyl-3-(1h-pyrazol-4-yl)prop-2-yn-1-amine | AA001BNT | MFCD22574187
1400764-19-3 | 3-Aminopyrazolo[1,5-a]pyrimidine tfa | AA001BX7 | MFCD22421658
1404309-51-8 | 4-Bromopyrazolo[1,5-a]pyridin-2-amine | AA001CCK | MFCD23106448
14080-58-1 | 4-Hydrazinylthieno[2,3-d]pyrimidine | AA001CPW | MFCD00728978
145428-94-0 | Strychnidin-10-one, 2,3-dimethoxy-, hydrate (1:2) | AA001CYS | MFCD00005942
145736-61-4 | 6-(2-Chloroacetyl)-2H-benzo[b][1,4]thiazin-3(4H)-one | AA001DAH | MFCD08276795
1461-67-2 | 5-Iodo-6-methylpyrimidine-2,4-diol | AA001DLZ | MFCD00192229
146368-11-8 | 3H-Indolium, 2-[5-[1-(5-carboxypentyl)-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene]-1,3-pentadien-1-yl]-1-ethyl-3,3-dimethyl-5-sulfo-, inner salt | AA001DVB | MFCD29477740